Serena Di Cosimo

机构：Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0002-4666-8052

发表论文 468 篇 · 总被引 10990 次 · h-index 50

代表论文

• Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial (2024 · Nature Communications · 被引 26)
• LBA23 ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreated HR-positive/HER2-negative advanced breast cancer (HR+/HER2- ABC) with aggressive disease criteria (2024 · Annals of Oncology · 被引 18)
• The role of radiation therapy in the multidisciplinary management of male breast cancer: A systematic review and meta-analysis on behalf of the Clinical Oncology Breast Cancer Group (COBCG) (2024 · Critical Reviews in Oncology/Hematology · 被引 14)
• Advancing breast cancer therapy in the era of molecular diagnostics (2025 · The Breast · 被引 11)
• Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024 · ESMO Open · 被引 11)
• From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer (2024 · Cancers · 被引 10)